[1] Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

[2] Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

[3] Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

[4] Colonization and infection with antibiotic-resistant bacteria in a long-term care facility

[5] Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

[6] Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism

[7] The changing pattern of infection in neutropenic patients

[8] Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections